CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C09604 | BRD-K22778609 | BRD-K22778609 | -- | -- | -- | Details |
C09605 | BRD-K22778679 | BRD-K22778679 | -- | -- | -- | Details |
C09606 | BRD-K22778942 | BRD-K22778942 | -- | -- | -- | Details |
C09607 | BRD-K22787051 | BRD-K22787051 | -- | -- | -- | Details |
C09608 | BRD-K22789469 | BRD-K22789469 | -- | -- | -- | Details |
C09609 | BRD-K22789789 | BRD-K22789789 | -- | -- | -- | Details |
C09610 | BRD-K22790182 | BRD-K22790182 | -- | -- | -- | Details |
C09611 | BRD-K22797212 | BRD-K22797212 | -- | -- | -- | Details |
C09612 | BRD-K22800340 | BRD-K22800340 | -- | -- | -- | Details |
C09613 | BRD-K22801678 | BRD-K22801678 | -- | -- | -- | Details |
C09614 | BRD-K22812176 | BRD-K22812176 | -- | -- | -- | Details |
C09615 | BRD-K22814206 | BRD-K22814206 | -- | -- | -- | Details |
C09616 | BRD-K22816026 | SA-1459167 | -- | -- | -- | Details |
C09617 | BRD-K22822991 | odanacatib | CTSK | Cathepsin inhibitor | -- | Details |
C09618 | BRD-K22825029 | BRD-K22825029 | -- | -- | -- | Details |
C09619 | BRD-K22827077 | BRD-K22827077 | -- | -- | -- | Details |
C09620 | BRD-K22828548 | BRD-K22828548 | -- | -- | -- | Details |
C09621 | BRD-K22828860 | BRD-K22828860 | -- | -- | -- | Details |
C09622 | BRD-K22828899 | TUL-XXI039 | -- | -- | -- | Details |
C09623 | BRD-K22831754 | BRD-K22831754 | -- | -- | -- | Details |
C09624 | BRD-K22832646 | MW-STK33-1A | -- | -- | -- | Details |
C09625 | BRD-K22836524 | BRD-K22836524 | -- | -- | -- | Details |
C09626 | BRD-K22839533 | BRD-K22839533 | -- | -- | -- | Details |
C09627 | BRD-K22846014 | BRD-K22846014 | -- | -- | -- | Details |
C09628 | BRD-K22847783 | BRD-K22847783 | -- | -- | -- | Details |
C09629 | BRD-K22848513 | BRD-K22848513 | -- | -- | bardoxolone-methyl | Details |
C09630 | BRD-K22853292 | BRD-K22853292 | -- | -- | -- | Details |
C09631 | BRD-K22854278 | BRD-K22854278 | -- | -- | -- | Details |
C09632 | BRD-K22854578 | BRD-K22854578 | -- | -- | -- | Details |
C09633 | BRD-K22854900 | BRD-K22854900 | -- | -- | -- | Details |
C09634 | BRD-K22861715 | chrysin | -- | -- | -- | Details |
C09635 | BRD-K22862802 | BRD-K22862802 | -- | -- | -- | Details |
C09636 | BRD-K22863062 | BRD-K22863062 | -- | -- | -- | Details |
C09637 | BRD-K22865069 | BRD-K22865069 | -- | -- | -- | Details |
C09638 | BRD-K22870904 | BRD-K22870904 | -- | -- | -- | Details |
C09639 | BRD-K22874335 | BRD-K22874335 | -- | -- | -- | Details |
C09640 | BRD-K22875057 | BRD-K22875057 | -- | -- | N-(3-methoxyphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide | Details |
C09641 | BRD-K22875065 | BRD-K22875065 | -- | -- | -- | Details |
C09642 | BRD-K22878149 | SB-205607 | OPRD1 | Delta 1 opioid receptor agonist | -- | Details |
C09643 | BRD-K22886798 | BRD-K22886798 | -- | -- | -- | Details |
C09644 | BRD-K22901619 | norgestimate | PGR | Progesterone receptor agonist | -- | Details |
C09645 | BRD-K22905567 | BRD-K22905567 | -- | -- | -- | Details |
C09646 | BRD-K22907310 | BRD-K22907310 | -- | -- | -- | Details |
C09647 | BRD-K22912836 | BRD-K22912836 | -- | -- | -- | Details |
C09648 | BRD-K22915992 | BRD-K22915992 | -- | -- | -- | Details |
C09649 | BRD-K22931010 | KM-00519SC | -- | -- | -- | Details |
C09650 | BRD-K22932079 | BRD-K22932079 | -- | -- | -- | Details |
C09651 | BRD-K22935984 | BRD-K22935984 | -- | -- | -- | Details |
C09652 | BRD-K22936972 | diphenylpyraline | HRH1; SLC6A3 | Dopamine uptake inhibitor | -- | Details |
C09653 | BRD-K22937431 | BRD-K22937431 | -- | -- | -- | Details |
C09654 | BRD-K22940496 | BRD-K22940496 | -- | -- | -- | Details |
C09655 | BRD-K22941245 | BRD-K22941245 | -- | -- | -- | Details |
C09656 | BRD-K22944564 | BRD-K22944564 | -- | -- | -- | Details |
C09657 | BRD-K22944782 | BRD-K22944782 | -- | -- | -- | Details |
C09658 | BRD-K22945779 | BRD-K22945779 | -- | -- | -- | Details |
C09659 | BRD-K22947005 | dexbrompheniramine | HRH1 | Histamine receptor antagonist | -- | Details |
C09660 | BRD-K22949587 | BRD-K22949587 | -- | -- | -- | Details |
C09661 | BRD-K22951866 | BRD-K22951866 | -- | -- | -- | Details |
C09662 | BRD-K22957824 | BRD-K22957824 | -- | -- | -- | Details |
C09663 | BRD-K22959724 | BRD-K22959724 | -- | -- | -- | Details |
C09664 | BRD-K22961642 | BRD-K22961642 | -- | -- | -- | Details |
C09665 | BRD-K22969690 | BRD-K22969690 | -- | -- | chloramphenicol | Details |
C09666 | BRD-K22970494 | BRD-K22970494 | -- | -- | -- | Details |
C09667 | BRD-K22974051 | BRD-K22974051 | -- | -- | -- | Details |
C09668 | BRD-K22983069 | BRD-K22983069 | -- | -- | -- | Details |
C09669 | BRD-K22988559 | BRD-K22988559 | -- | -- | -- | Details |
C09670 | BRD-K22988729 | BRD-K22988729 | -- | -- | -- | Details |
C09671 | BRD-K23001296 | BRD-K23001296 | -- | -- | -- | Details |
C09672 | BRD-K23011225 | BRD-K23011225 | -- | -- | -- | Details |
C09673 | BRD-K23017938 | BRD-K23017938 | -- | -- | -- | Details |
C09674 | BRD-K23018071 | BRD-K23018071 | -- | -- | -- | Details |
C09675 | BRD-K23020884 | BRD-K23020884 | -- | -- | -- | Details |
C09676 | BRD-K23021002 | BRD-K23021002 | -- | -- | -- | Details |
C09677 | BRD-K23024526 | BRD-K23024526 | -- | -- | -- | Details |
C09678 | BRD-K23027438 | BRD-K23027438 | -- | -- | -- | Details |
C09679 | BRD-K23029982 | BRD-K23029982 | -- | -- | -- | Details |
C09680 | BRD-K23033683 | BRD-K23033683 | -- | -- | -- | Details |
C09681 | BRD-K23038591 | BRD-K23038591 | -- | -- | -- | Details |
C09682 | BRD-K23047495 | BRD-K23047495 | -- | -- | -- | Details |
C09683 | BRD-K23050218 | BRD-K23050218 | -- | -- | -- | Details |
C09684 | BRD-K23051555 | BRD-K23051555 | -- | -- | -- | Details |
C09685 | BRD-K23051691 | BRD-K23051691 | -- | -- | -- | Details |
C09686 | BRD-K23058957 | BRD-K23058957 | -- | -- | -- | Details |
C09687 | BRD-K23060602 | BRD-K23060602 | -- | -- | -- | Details |
C09688 | BRD-K23060864 | BRD-K23060864 | -- | -- | -- | Details |
C09689 | BRD-K23062161 | BRD-K23062161 | -- | -- | -- | Details |
C09690 | BRD-K23062575 | BRD-K23062575 | -- | -- | -- | Details |
C09691 | BRD-K23064726 | BRD-K23064726 | -- | -- | -- | Details |
C09692 | BRD-K23073505 | BRD-K23073505 | -- | -- | -- | Details |
C09693 | BRD-K23075656 | BRD-K23075656 | -- | -- | -- | Details |
C09694 | BRD-K23077259 | BRD-K23077259 | -- | -- | -- | Details |
C09695 | BRD-K23082237 | butaclamol | DRD1; DRD2; DRD3 | Dopamine receptor antagonist | -- | Details |
C09696 | BRD-K23085156 | BRD-K23085156 | -- | -- | -- | Details |
C09697 | BRD-K23091084 | BRD-K23091084 | -- | -- | -- | Details |
C09698 | BRD-K23091373 | BRD-K23091373 | -- | -- | -- | Details |
C09699 | BRD-K23103632 | BRD-K23103632 | -- | -- | -- | Details |
C09700 | BRD-K23108726 | BRD-K23108726 | -- | -- | -- | Details |
C09701 | BRD-K23112275 | BRD-K23112275 | -- | -- | -- | Details |
C09702 | BRD-K23117210 | BRD-K23117210 | -- | -- | -- | Details |
C09703 | BRD-K23118252 | BRD-K23118252 | -- | -- | -- | Details |